Item request has been placed!
×
Item request cannot be made.
×
Processing Request
[Impaired expression of Act1mRNA in B cells of patients with Sjögren's syndrome].
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Nihon Rinshō Men'eki Gakkai Country of Publication: Japan NLM ID: 9505992 Publication Model: Print Cited Medium: Internet ISSN: 1349-7413 (Electronic) Linking ISSN: 09114300 NLM ISO Abbreviation: Nihon Rinsho Meneki Gakkai Kaishi Subsets: MEDLINE
- Publication Information:
Publication: Tōkyō : Nihon Rinshō Men'eki Gakkai
Original Publication: Tōkyō : Dō Gakkai
- Subject Terms:
- Abstract:
Sjögren's syndrome (SS) is a systemic autoimmune disorder characterized by profound lymphocytic infiltration into the lacrimal and salivary glands, thereby diminished secretory function. B cell hyper-activation is a predominant feature of SS related to hypergammaglobulinemia and production of autoantibodies. The adaptor molecule NF-kB activator 1 (Act1) plays an important role in the homeostasis of B cells by attenuating CD40 and B cell-activating factor belonging to the tumor necrosis factor family receptor (BAFFR) signaling. Act1-deficient mice develop autoimmune manifestations similar to SS, which are hypergammaglobulinemia, high levels of anti-SSA and anti-SSB autoantibodies. In this study, to investigate the role of Act1 in the pathogenesis of SS, we examined Act1mRNA expressions in B cells from patients with SS and discussed the association of Act1 with parameters and clinical manifestations of SS. We showed the low level of Act1mRNA expression in patients with SS and reciprocal association of Act1 with serum IgG level. Diminished Act1mRNA expression in SS may be associated with B cell hyperactivity and elevated immunoglobulin production in SS by uncontrolled B cell activation signal through CD40 and BAFFR.
- Accession Number:
0 (ACT1 protein)
0 (Connexin 43)
0 (Peptide Fragments)
0 (RNA, Messenger)
- Publication Date:
Date Created: 20120301 Date Completed: 20120507 Latest Revision: 20191112
- Publication Date:
20231215
- Accession Number:
10.2177/jsci.35.75
- Accession Number:
22374447
No Comments.